Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
about
Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Andrographolide inhibits prost ...... and CXCR7 chemokine receptors.
@en
type
label
Andrographolide inhibits prost ...... and CXCR7 chemokine receptors.
@en
prefLabel
Andrographolide inhibits prost ...... and CXCR7 chemokine receptors.
@en
P2093
P2860
P1433
P1476
Andrographolide inhibits prost ...... and CXCR7 chemokine receptors
@en
P2093
Guru Sonpavde
James W Lillard
Neeraj Kapur
Rajesh Singh
Shailesh Singh
P2860
P304
P356
10.1080/15384101.2016.1148836
P50
P577
2016-01-01T00:00:00Z